Amyloid biomarkers as predictors of conversion from mild cognitive impairment to Alzheimer’s dementia: a comparison of methods

BACKGROUND: Amyloid-β (Aβ) PET is an established predictor of conversion from mild cognitive impairment (MCI) to Alzheimer’s dementia (AD). We compared three PET (including an approach based on voxel-wise Cox regression) and one cerebrospinal fluid (CSF) outcome measures in their predictive power. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Sörensen, Arnd, Blazhenets, Ganna, Schiller, Florian, Meyer, Philipp Tobias, Frings, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678323/
https://www.ncbi.nlm.nih.gov/pubmed/33213489
http://dx.doi.org/10.1186/s13195-020-00721-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678323/
https://www.ncbi.nlm.nih.gov/pubmed/33213489
http://dx.doi.org/10.1186/s13195-020-00721-3

Ejemplares similares